Tirzepatide vs Ozempic: which is better for weight loss?
Quick answer
In the SURMOUNT-5 head-to-head trial, tirzepatide produced 20.2% weight loss vs 13.7% for semaglutide (the active ingredient in Ozempic/Wegovy) over 72 weeks -- 47% more weight loss. Side effect profiles were comparable between the two drugs.
The head-to-head data
SURMOUNT-5 was the first randomized controlled trial directly comparing tirzepatide and semaglutide. Published in the New England Journal of Medicine in 2024, it enrolled 751 adults with obesity and no diabetes.
At maximum tolerated doses over 72 weeks: tirzepatide patients lost 20.2% of body weight vs 13.7% for semaglutide. For a 230 lb person, that translates to roughly 46.5 lbs (tirzepatide) vs 31.5 lbs (semaglutide) -- a 15 lb difference. Approximately 1 in 3 tirzepatide patients lost over 25% body weight vs 1 in 10 on semaglutide.
Why the difference exists
Semaglutide (Ozempic/Wegovy) activates GLP-1 receptors only. Tirzepatide activates both GLP-1 and GIP receptors. GIP receptors play a role in fat metabolism, insulin secretion, and energy expenditure that GLP-1 alone doesn't fully address.
The dual mechanism appears to produce stronger appetite suppression and potentially better fat-specific loss (as opposed to lean mass loss). Both drugs slow gastric emptying and reduce hunger signals to the brain, but tirzepatide does it through two pathways instead of one.
Side effects comparison
In SURMOUNT-5, both drugs had similar GI side effect rates. Nausea, diarrhea, vomiting, and constipation were the most common adverse events in both groups. The additional weight loss from tirzepatide did not come with significantly more side effects.
This is important because it means tirzepatide isn't just a "stronger" drug with worse tolerability. It's a mechanistically different drug that produces more weight loss without proportionally more side effects.
Cost and access considerations
Brand-name Ozempic and Wegovy (semaglutide) list at $900-1,350/month without insurance. Brand-name Mounjaro/Zepbound (tirzepatide) is in the same range. Insurance coverage varies significantly by plan and indication.
Compounded versions of both medications exist at substantially lower price points. LYV offers compounded tirzepatide starting at $197/month, prescribed by licensed providers and shipped from US pharmacies. The compounded route makes tirzepatide accessible to people who can't get insurance coverage or afford brand pricing.
Learn more about Tirzepatide
Frequently asked questions
Is Ozempic or tirzepatide better for weight loss?
Tirzepatide produces more weight loss on average. The SURMOUNT-5 trial showed 47% more weight reduction with tirzepatide vs semaglutide over 72 weeks, with comparable side effects. However, individual response varies. Some people respond very well to semaglutide.
Can I switch from Ozempic to tirzepatide?
Yes, switching is common and straightforward. Most prescribers will start tirzepatide at the 2.5mg dose regardless of your previous semaglutide dose, then titrate up. You may experience some renewed GI side effects as your body adjusts to the different mechanism.
Do Ozempic and tirzepatide have the same side effects?
The side effect profiles are very similar. Both primarily cause GI symptoms: nausea, diarrhea, constipation, and reduced appetite. Rates are comparable in head-to-head data. Neither drug has shown a significantly worse safety profile than the other in clinical trials.
Get the right protocol for your goals
Take a 2-minute quiz. Matched to your health profile by a licensed provider.